Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 847.00
-2.45 (-0.29%)
Sep 18, 2025, 12:31 PM IST
Krsnaa Diagnostics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
| 7,399 | 7,172 | 6,196 | 4,871 | 4,555 | 3,965 | Upgrade | |
Revenue Growth (YoY) | 13.78% | 15.74% | 27.20% | 6.95% | 14.88% | 53.41% | Upgrade |
Cost of Revenue | 1,738 | 1,727 | 1,513 | 899.54 | 755.7 | 949.21 | Upgrade |
Gross Profit | 5,661 | 5,445 | 4,683 | 3,972 | 3,799 | 3,015 | Upgrade |
Selling, General & Admin | 2,030 | 2,046 | 1,888 | 1,680 | 1,724 | 1,464 | Upgrade |
Other Operating Expenses | 1,643 | 1,498 | 1,353 | 1,062 | 757.77 | 607.91 | Upgrade |
Operating Expenses | 4,558 | 4,427 | 3,987 | 3,279 | 2,895 | 2,447 | Upgrade |
Operating Income | 1,104 | 1,018 | 696.44 | 692.39 | 903.37 | 568.78 | Upgrade |
Interest Expense | -256.35 | -217.58 | -140.87 | -64.35 | -168.63 | -249.27 | Upgrade |
Interest & Investment Income | - | 167 | 167.6 | 181.24 | 149.09 | 122.25 | Upgrade |
Other Non Operating Income (Expenses) | 221.69 | 12.96 | -23.67 | -9.03 | -16.27 | -10.02 | Upgrade |
EBT Excluding Unusual Items | 1,069 | 980.03 | 699.5 | 800.25 | 867.56 | 431.74 | Upgrade |
Gain (Loss) on Sale of Assets | - | 46.84 | 0.57 | 1.76 | -2.48 | -5.06 | Upgrade |
Other Unusual Items | - | - | - | - | - | 2,528 | Upgrade |
Pretax Income | 1,069 | 1,027 | 700.07 | 802.01 | 865.08 | 2,955 | Upgrade |
Income Tax Expense | 267 | 250.79 | 131.7 | 180.9 | 181.2 | 1,105 | Upgrade |
Net Income | 802.07 | 776.08 | 568.37 | 621.11 | 683.88 | 1,849 | Upgrade |
Net Income to Common | 802.07 | 776.08 | 568.37 | 621.11 | 683.88 | 1,849 | Upgrade |
Net Income Growth | 33.42% | 36.55% | -8.49% | -9.18% | -63.02% | - | Upgrade |
Shares Outstanding (Basic) | 32 | 32 | 32 | 31 | 30 | 12 | Upgrade |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 32 | 30 | 26 | Upgrade |
Shares Change (YoY) | 0.01% | 0.33% | 1.99% | 7.74% | 16.13% | 149.21% | Upgrade |
EPS (Basic) | 24.84 | 24.03 | 17.90 | 19.78 | 22.89 | 160.36 | Upgrade |
EPS (Diluted) | 24.35 | 23.56 | 17.31 | 19.29 | 22.88 | 12.25 | Upgrade |
EPS Growth | 33.42% | 36.11% | -10.26% | -15.69% | 86.72% | - | Upgrade |
Free Cash Flow | - | -393 | -1,695 | -650.59 | -37.95 | 357.18 | Upgrade |
Free Cash Flow Per Share | - | -11.93 | -51.63 | -20.21 | -1.27 | 13.88 | Upgrade |
Dividend Per Share | - | 2.750 | 2.500 | 2.750 | 2.500 | - | Upgrade |
Dividend Growth | - | 10.00% | -9.09% | 10.00% | - | - | Upgrade |
Gross Margin | 76.51% | 75.92% | 75.58% | 81.53% | 83.41% | 76.06% | Upgrade |
Operating Margin | 14.92% | 14.19% | 11.24% | 14.21% | 19.84% | 14.35% | Upgrade |
Profit Margin | 10.84% | 10.82% | 9.17% | 12.75% | 15.02% | 46.65% | Upgrade |
Free Cash Flow Margin | - | -5.48% | -27.36% | -13.36% | -0.83% | 9.01% | Upgrade |
EBITDA | 2,041 | 1,799 | 1,365 | 1,220 | 1,312 | 929.6 | Upgrade |
EBITDA Margin | 27.58% | 25.08% | 22.02% | 25.04% | 28.81% | 23.45% | Upgrade |
D&A For EBITDA | 937.03 | 780.99 | 668.07 | 527.33 | 408.85 | 360.82 | Upgrade |
EBIT | 1,104 | 1,018 | 696.44 | 692.39 | 903.37 | 568.78 | Upgrade |
EBIT Margin | 14.92% | 14.19% | 11.24% | 14.21% | 19.84% | 14.35% | Upgrade |
Effective Tax Rate | 24.98% | 24.42% | 18.81% | 22.56% | 20.95% | 37.41% | Upgrade |
Revenue as Reported | 7,621 | 7,427 | 6,364 | 5,065 | 4,704 | 6,615 | Upgrade |
Advertising Expenses | - | 19.81 | 29.36 | 31.91 | 18.09 | 10.33 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.